(Natural News) Back in 2011, pharmaceutical giant Pfizer signed a memorandum of understanding with a China-based drug manufacturer called Shanghai Pharmaceutical Co. Ltd. that we now know supported the “military combat” efforts of the communist regime’s People’s Liberation Army (PLA).
Pfizer reportedly approached the Chinese military-linked pharmaceutical firm to expand its own market access into China, and Shanghai Pharmaceutical saw this as an opportunity “for the companies to jointly pursue potential business opportunities in China,” according to the memo.
“The potential partnership is intended to leverage both companies’ strengths,” Pfizer proudly announced at the time, adding that the deal would result in “matching Pfizer’s global capabilities in developing innovative medicines with Shanghai Pharmaceutical’s capabilities and reach in the China market.”
“The companies plan to explore future cooperation opportunities, including further distribution and commercialization, research and development activities, manufacturing and equity investment opportunities,” it was further revealed as part of an information leak.
Another Shanghai Pharmaceutical partner linked to Wuhan Institute of Virology
More than a decade has gone by since, and Pfizer’s little partnership with this Chinese Communist Party (CCP)-linked operation is finally coming out in the open, as are the terms that Shanghai Pharmaceutical is bound to suggest treason on the part of Pfizer.
According to reports, Shanghai Pharmaceutical is subject to Article 7 of China’s National Intelligence Law, which requires that “any [Chinese] organization or citizen shall support, assist, and cooperate with state intelligence work.”
An unearthed “Corporate Social Responsibility Report” from 2020 also reveals that Shanghai Pharmaceutical’s longstanding collaborations with the PLA involved “organizing and implementing drug storage on behalf of the military combat,” a project that was worth roughly $2.4 million.
“In addition, since 2007, [Shanghai Pharmaceutical] has begun to organize and implement drug storage on behalf of the military combat,” the documents further explain.
“The amount was more than RMB15 million, and Shanghai Pharma was the storage enterprise while other subsidiaries acted as emergency units. It is now the East China region (Shanghai) drug security mobilization center.”
If that is not all bad enough, it also came out that Shanghai Pharmaceutical was partnered with China’s Secondary Military Medical University (SMMU), also known as the People’s Liberation Army Naval Medical University.
This partnership forged a plan for Shanghai Pharmaceutical to provide “a certain amount of R&D (research and development) funding input annually for the establishment of advance of ‘SMMU – Shanghai Pharmaceutical Translational Medicine Alliance’ to carry out R&D cooperation in fields of new medicine and medical devices development and so forth,” a press release explained.
In other words, Shanghai Pharmaceutical has been working for the Chinese military to develop new drugs and medical devices. Keep in mind that the Chinese military and its government are enemies of the United States, geopolitically speaking.
But wait, there is more: SMMU also reportedly has ties to the Wuhan Institute of Virology (WIV), which is the place where the Wuhan coronavirus (Covid-19) is believed to have originated.
The Deputy Director of WIV’s Academic Committee, Hongyang Wang, had a listed affiliation with SMMU on the school’s website before it was mysteriously scrubbed in mid-2020.
The Chinese military has been pushing for a “vaccine passport” system since at least 2018, which was well before the plandemic began, just to be clear. And Pfizer, which we now know has been working with the Chinese military, also just so happens to be pushing for jab passports.
Meanwhile, Pfizer’s U.S. lobbying efforts for this and other devious schemes reached an all-time high in 2021 at the height of the plandemic. It must all just be a coincidence, right?
More related news coverage about Pfizer can be found at Corruption.news.
Sources for this article include: